Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840
Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses
Apostolia-Maria Tsimberidou, Sijin Wen, David S Hong, et al.
Breast Cancer Research : BCR
|
November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee
Lesley Seymour, S Percy Ivy, Daniel Sargent, et al.
Expert Review of Neurotherapeutics
|
December 27, 2014
Charting a path toward combination therapy for Alzheimer's disease
Diane Stephenson, Dan Perry, Cynthia Bens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes
Lanlan Shen, Hagop Kantarjian, Yi Guo, et al.
Breast Cancer Research and Treatment
|
June 15, 2006
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2012
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative
Apostolia-Maria Tsimberidou, Nancy G Iskander, David S Hong, et al.
Journal of the National Cancer Institute
|
June 27, 2015
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
Jennifer A Ligibel, Constance T Cirrincione, Minetta Liu, et al.
The Lancet. Oncology
|
September 16, 2021
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
Joe Y Chang, Reza J Mehran, Lei Feng, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840
Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses
Apostolia-Maria Tsimberidou, Sijin Wen, David S Hong, et al.
Breast Cancer Research : BCR
|
November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee
Lesley Seymour, S Percy Ivy, Daniel Sargent, et al.
Expert Review of Neurotherapeutics
|
December 27, 2014
Charting a path toward combination therapy for Alzheimer's disease
Diane Stephenson, Dan Perry, Cynthia Bens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes
Lanlan Shen, Hagop Kantarjian, Yi Guo, et al.
Breast Cancer Research and Treatment
|
June 15, 2006
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2012
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative
Apostolia-Maria Tsimberidou, Nancy G Iskander, David S Hong, et al.
Journal of the National Cancer Institute
|
June 27, 2015
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
Jennifer A Ligibel, Constance T Cirrincione, Minetta Liu, et al.
The Lancet. Oncology
|
September 16, 2021
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
Joe Y Chang, Reza J Mehran, Lei Feng, et al.
Page
of 6